Shifting Perceptions of CRISPR

Photo by National Cancer Institute on Unsplash INTRODUCTION More than 20 cell and gene therapies are now available to safely minimize genetic diseases such as retinal dystrophy (LUXTURNA), some B-cell lymphomas (YESCARTA), and B-cell lymphoblastic leukemia (KYMRIAH).[1] One such gene-ed...

Full description

Bibliographic Details
Main Author: Camille Castelyn
Format: Article
Language:English
Published: Columbia University Libraries 2021-08-01
Series:Voices in Bioethics
Subjects:
Online Access:https://journals.library.columbia.edu/index.php/bioethics/article/view/8595